Although the correlation was good (r = 0.69, P < 0.0001), they found that 52% of the PASP measurements using TTE were inaccurate and 48% of the patients were misclassified as having PAH if the diagnosis was based on TTE alone. This evidence concerns the gene CPB1 and pulmonary arterial hypertension.